Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) shares were down 7.7% on Tuesday . The stock traded as low as $9.37 and last traded at $9.37. Approximately 750 shares were traded during trading, a decline of 48% from the average daily volume of 1,441 shares. The stock had previously closed at $10.15.
Sumitomo Pharma Stock Performance
The company’s 50-day moving average is $11.54 and its two-hundred day moving average is $13.50.
About Sumitomo Pharma
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
Recommended Stories
- Five stocks we like better than Sumitomo Pharma
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
